Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial

OpT2mise: A Randomized Controlled Trial to Compare Insulin Pump Therapy with Multiple Daily Injections in the Treatment of Type 2 Diabetes—Research Design and Methods

(2014) Ronnie Aronson et al.   Diabetes Technology & Therapeutics

Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial

(2014) Yves Reznik et al.   LANCET

Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes

(2014) GUAN-QI GAO et al.   Experimental and Therapeutic Medicine

Insulin Pump for Type 2 Diabetes: Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes

(2013) Y. Reznik et al.   DIABETES CARE

Randomized, 1-year comparison of three ways to initiate and advance insulin for type 2 diabetes: twice-daily premixed insulin versus basal insulin with either basal-plus one prandial insulin or basal-bolus up to three prandial injections

(2013) M. C. Riddle et al.   DIABETES OBESITY & METABOLISM

O42 Traitement par pompe à insuline dans le diabète de type 2 (DT2): 12 ans de suivi d’une cohorte de 50 patients

(2012) L. Charras et al.   DIABETES & METABOLISM

PMD19 Multiple Daily Injection Therapy (MDI) Versus Durable Insulin Pump Therapy in Type II Diabetics: A Breakeven Analysis

(2012) G. David et al.   VALUE IN HEALTH

Insulin Pump Therapy in Patients with Type 2 Diabetes Safely Improved Glycemic Control Using a Simple Insulin Dosing Regimen

(2010) Steven V. Edelman et al.   Diabetes Technology & Therapeutics

Efficacy of Continuous Subcutaneous Insulin Infusion in Type 2 Diabetes Mellitus: A Survey on a Cohort of 102 Patients with Prolonged Follow-Up

(2010) Yves Reznik et al.   Diabetes Technology & Therapeutics

Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus

(2009) Adriaan Kooy et al.   ARCHIVES OF INTERNAL MEDICINE

Reduction of Glycosylated Hemoglobin Following 6 Months of Continuous Subcutaneous Insulin Infusion in an Indian Population with Type 2 Diabetes

(2009) Jothydev Kesavadev et al.   Diabetes Technology & Therapeutics

Hypoglycemia with Intensive Insulin Therapy: A Systematic Review and Meta-Analyses of Randomized Trials of Continuous Subcutaneous Insulin InfusionVersusMultiple Daily Injections

(2008) Mitra M. Fatourechi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM